These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 9049232)

  • 1. Iron and chronic viral hepatitis.
    Bonkovsky HL; Banner BF; Rothman AL
    Hepatology; 1997 Mar; 25(3):759-68. PubMed ID: 9049232
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatic iron stainings in chronic hepatitis C patients with low HCV RNA levels: a predictive marker for IFN therapy.
    Akiyoshi F; Sata M; Uchimura Y; Suzuki H; Tanikawa K
    Am J Gastroenterol; 1997 Sep; 92(9):1463-6. PubMed ID: 9317063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum iron parameters in patients with alcoholic and chronic cirrhosis and hepatitis.
    Jurczyk K; Wawrzynowicz-Syczewska M; Boroń-Kaczmarska A; Sych Z
    Med Sci Monit; 2001; 7(5):962-5. PubMed ID: 11535942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of chronic viral hepatitis: the end of the beginning?
    Dusheiko G
    Br J Hosp Med; 1994 Jun 15-Jul 12; 52(1):8-11. PubMed ID: 7524985
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment and prevention of chronic viral hepatitis].
    Lumio J; Vuoristo M
    Duodecim; 1994; 110(20):1883-92. PubMed ID: 7555802
    [No Abstract]   [Full Text] [Related]  

  • 6. Chronic hepatitis B.
    Schalm SW; Thomas HC; Hadziyannis SJ
    Prog Liver Dis; 1990; 9():443-62. PubMed ID: 2156307
    [No Abstract]   [Full Text] [Related]  

  • 7. [Optimal antiviral therapy of chronic hepatitis caused by hepatitis C virus].
    Cooreman MP; Stadhouders P
    Orv Hetil; 1997 Jun; 138(22 Suppl 1):1476-82. PubMed ID: 9221377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of serum paraoxonase-1 activity as a potential biomarker for chronic liver impairment.
    Camps J; Marsillach J; Joven J
    Clin Chim Acta; 2007; 386(1-2):114-5. PubMed ID: 17850780
    [No Abstract]   [Full Text] [Related]  

  • 9. Alpha-fetoprotein and hepatitis B virus infection in chronic liver disease.
    Solinas A; Madeddu G; Tocco A; Deplano A; Diana MS; Pirisi M; Marras G; Casu AR; Dore F; Langer M
    J Nucl Med Allied Sci; 1987; 31(2):183-8. PubMed ID: 2442327
    [No Abstract]   [Full Text] [Related]  

  • 10. Circulating markers of oxidative stress and liver fibrosis in Sudanese subjects at risk of schistosomiasis and hepatitis.
    Eboumbou C; Steghens JP; Abdallahi OM; Mirghani A; Gallian P; van Kappel A; Qurashi A; Gharib B; De Reggi M
    Acta Trop; 2005 May; 94(2):99-106. PubMed ID: 15814296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cryoglobulinemia in chronic liver diseases: cause or consequence?].
    Csepregi A; Nemesánszky E
    Orv Hetil; 1997 Mar; 138(11):651-6. PubMed ID: 9102622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lipid peroxidation and metabolism in viral hepatitis B and liver cirrhosis].
    Diadik VP; Bychkova VI
    Vrach Delo; 1986 Nov; (11):114-7. PubMed ID: 3825031
    [No Abstract]   [Full Text] [Related]  

  • 13. [Antiviral therapy in chronic hepatitis B: wishful thinking or reality?].
    Schalm SW
    Ned Tijdschr Geneeskd; 1987 Jul; 131(28):1209-11. PubMed ID: 2441271
    [No Abstract]   [Full Text] [Related]  

  • 14. Combined effect of an ACE inhibitor, perindopril, and interferon on liver fibrosis markers in patients with chronic hepatitis C.
    Yoshiji H; Noguchi R; Fukui H
    J Gastroenterol; 2005 Feb; 40(2):215-6. PubMed ID: 15770410
    [No Abstract]   [Full Text] [Related]  

  • 15. [Enzyme activity and dynamics of blood levels of microelements during the complex treatment of chronic liver diseases].
    Neĭko VE
    Vrach Delo; 1985 Jun; (6):61-3. PubMed ID: 4024589
    [No Abstract]   [Full Text] [Related]  

  • 16. Depression in chronic hepatitis: the virus, the drug, or the ethnic background?
    Ferenci P; Staufer K
    Liver Int; 2008 Apr; 28(4):429-31. PubMed ID: 18339069
    [No Abstract]   [Full Text] [Related]  

  • 17. Alcohol and viral hepatitis: a mini-review.
    Gitto S; Micco L; Conti F; Andreone P; Bernardi M
    Dig Liver Dis; 2009 Jan; 41(1):67-70. PubMed ID: 18602355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The significance of sIL-2R detection in various hepatic diseases].
    Xuan SY; Jiang LM; Lu WH
    Zhonghua Liu Xing Bing Xue Za Zhi; 1997 Apr; 18(2):92-4. PubMed ID: 9812507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors accelerating liver fibrosis progression in renal transplant patients receiving ribavirin monotherapy for chronic hepatitis C.
    Kamar N; Boulestin A; Selves J; Esposito L; Sandres-Saune K; Stébenet M; Chatelut E; Durand D; Rostaing L; Izopet J
    J Med Virol; 2005 May; 76(1):61-8. PubMed ID: 15778976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Interferon system in viral hepatitis].
    Lisker Melman M
    Rev Invest Clin; 1990 Jul; 42 Suppl():92-6. PubMed ID: 19256144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.